Evidence map›Paper›PMID 40421115›Full record

ReviewFrontiers in bioengineering and biotechnology2025

Shaping the future of tobacco through microbial insights: a review of advances and applications.

Wei Hu, Jiaxing Yuan, Jiaxiang Fei, Kaleem Imdad, Pengfei Yang, Shen Huang, Duobin Mao, Jing Yang

Abstract readReview
In one paragraph

Review in Frontiers in bioengineering and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Wei HuCollege of Tobacco Science and Engineering, Zhengzhou University of Light Industry, Zhengzhou, China.
Jiaxing YuanCollege of Tobacco Science and Engineering, Zhengzhou University of Light Industry, Zhengzhou, China.
Jiaxiang FeiTechnology Research Developing Center, Shenzhen Tobacco Industrial Co., Ltd., Shenzhen, China.
Kaleem ImdadDepartment of Biosciences, COMSATS University Islamabad, Islamabad, Pakistan.
Pengfei YangCollege of Tobacco Science and Engineering, Zhengzhou University of Light Industry, Zhengzhou, China.
Shen HuangCollege of Tobacco Science and Engineering, Zhengzhou University of Light Industry, Zhengzhou, China.
Duobin MaoCollege of Tobacco Science and Engineering, Zhengzhou University of Light Industry, Zhengzhou, China.
Jing YangCollege of Tobacco Science and Engineering, Zhengzhou University of Light Industry, Zhengzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the past 20 years, researchers have used multi-omics techniques to study microbial diversity and metabolic function on tobacco leaves. The unique metabolic function of tobacco microorganisms has attracted extensive attention from researchers, which is an important research field in tobacco industry to improve the intrinsic quality of tobacco leaf with microbial agents. The microorganisms are particularly rich on the surface of tobacco leaf, and their metabolic function is closely related to the change of tobacco leaf chemical composition. Some microorganisms have important metabolic functions, such as: degrading macromolecular and harmful substances in tobacco leaves, and they have different degradation rates and pathways for the substances. At present, many functions of tobacco leaf microorganisms have not been fully verified and analyzed. In the future, more novel culture methods are needed to screen and isolate microorganisms on the surface of tobacco leaves, deeply tap their metabolic potential, explore the application value of microorganisms in the tobacco industry, and further promote the innovation and development of the industry.

Indexed as

community compositionfunctionsisolation and cultivation strategiesmicroorganismtobacco

Identifiers

PMID40421115
PMCPMC12104242

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.